2018
DOI: 10.1002/humu.23647
|View full text |Cite
|
Sign up to set email alerts
|

The intellectual disability-associated CAMK2G p.Arg292Pro mutation acts as a pathogenic gain-of-function

Abstract: The abundantly expressed calcium/calmodulin-dependent protein kinase II (CAMK2) alpha (CAMK2A) and beta (CAMK2B) isoforms are essential for learning and memory formation. Recently, a de novo candidate mutation (p.Arg292Pro) in the gamma isoform of CAMK2 (CAMK2G) was identified in a patient with severe intellectual disability (ID), but the mechanism(s) by which this mutation causes ID is unknown. Here we identified a second, unrelated individual, with a de novo CAMK2G p.Arg292Pro mutation, and used in vivo and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1

Relationship

5
2

Authors

Journals

citations
Cited by 28 publications
(31 citation statements)
references
References 47 publications
(83 reference statements)
0
30
1
Order By: Relevance
“…The complementary DNA (cDNA) sequence from human TAOK1 WT (NM_020791.2) was obtained from a human brain cDNA library by polymerase chain reaction (PCR) (Phusion high fidelity; Thermo Fisher Scientific) using the following primers: Fw 5’‐GGCGCGCCTCCATGGGCCCATCAACTAACAGAGCAGG‐3’ and Rev 5’‐TTAATTAAGCGGCCGCTTATGTATAAGACATGTGTGACCC‐3’ and cloned into our dual promoter expression vector containing the CAGG promoter to drive transcription of the gene of interest and a separate PGK promoter for transcription of the tdTomato gene (Küry et al, 2017; Proietti Onori et al, 2018; Reijnders et al, 2017). The single‐nucleotide point mutation was introduced by PCR (Phusion high fidelity, Thermo Fisher Scientific) using the following primers: TAOK1 –c.449G>T (p.Arg150Ile), Fw 5’‐CATTCTCATACTATGATTCATATAGATATCAAAGCAGGAAATATC‐3’ and Rev 5’‐GATATTTCCTGCTTTGATATCTATATGAATCATAGTATGAGAATG‐3’.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The complementary DNA (cDNA) sequence from human TAOK1 WT (NM_020791.2) was obtained from a human brain cDNA library by polymerase chain reaction (PCR) (Phusion high fidelity; Thermo Fisher Scientific) using the following primers: Fw 5’‐GGCGCGCCTCCATGGGCCCATCAACTAACAGAGCAGG‐3’ and Rev 5’‐TTAATTAAGCGGCCGCTTATGTATAAGACATGTGTGACCC‐3’ and cloned into our dual promoter expression vector containing the CAGG promoter to drive transcription of the gene of interest and a separate PGK promoter for transcription of the tdTomato gene (Küry et al, 2017; Proietti Onori et al, 2018; Reijnders et al, 2017). The single‐nucleotide point mutation was introduced by PCR (Phusion high fidelity, Thermo Fisher Scientific) using the following primers: TAOK1 –c.449G>T (p.Arg150Ile), Fw 5’‐CATTCTCATACTATGATTCATATAGATATCAAAGCAGGAAATATC‐3’ and Rev 5’‐GATATTTCCTGCTTTGATATCTATATGAATCATAGTATGAGAATG‐3’.…”
Section: Methodsmentioning
confidence: 99%
“…The procedure was performed as described previously (Proietti Onori et al, 2018). In short, pregnant FvB/NHsD mice at E14.5 of gestation were anesthetized, and the uterus was exposed.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Plasmids were all rat: pCMV6-CaMKIIα-Myc-DDK, (#RR201121), pCMV6-CaMKIIγ-Myc-DDK (#RR207416), pCMV6-CaMKIIδ-Myc-DDK (#RR209882), all from Addgene, pCAGG-CaMKIIβ-pPGK-tdTOMATO 37 . Mutations R433Q, R453Q, R469Q, H395A and the triple mutant R433/453/469Q in CaMKIIα in pCMV6-Myc-DDK were generated and sequence-verified by GenScript.…”
Section: Methods Sectionmentioning
confidence: 99%
“…pCMV(pr)Camk2a-pCamkII(pr)eCFP and pCMV(pr)Camk2b-pCamkII(pr)eCFP were created by substituting tdTomato to eCFP from the plasmid in [83]. pSyn(pr)Synapsin-mCherry [39], pSyn(pr)BDNF-pHluorin, and pSyn(pr)BDNF-mCherry were engineered by replacing NPY with cDNA of BDNF from the plasmid encoding pSyn(pr)NPY-pHluorin [38] and pSyn (pr)NPY-mCherry [38].…”
Section: Plasmid and Lentiviral Infectionmentioning
confidence: 99%